Orotic acid-induced metabolic changes in the rat

Area of Science:

• Biochemistry
• Metabolic research
• Hepatology

Background:

• Orotic acid is a key intermediate in pyrimidine biosynthesis.
• Hepatic lipid metabolism and nucleotide metabolism are closely interconnected.
• Understanding the impact of exogenous orotic acid on these pathways is crucial for metabolic research.

Purpose of the Study:

• To investigate the concurrent effects of orotic acid consumption on hepatic lipid and nucleotide metabolism in rats.
• To determine the dose-dependent and time-course effects of orotic acid.
• To explore the potential role of nucleotide alterations in the etiology of fatty liver.

Main Methods:

• Rats were fed diets containing varying concentrations of orotic acid (0.1%, 0.5%, 1.0%) for different durations (3, 7, 10 days).
• Hepatic lipid accumulation (steatosis) and nucleotide profiles (purine/pyrimidine ratio) were analyzed.
• Hepatomegaly was assessed as an indicator of liver changes.

Main Results:

• Orotic acid consumption at 1.0% led to fatty liver by day 7, preceded by decreased purine/pyrimidine ratios by day 3.
• Dose-dependent effects were observed: 0.5% and 1.0% orotic acid induced fatty liver and altered nucleotide ratios, while 0.1% did not.
• L-dihydroorotate mimicked orotic acid's effects, while uridine did not.

Conclusions:

• Orotic acid, at levels above 0.1%, significantly alters hepatic lipid and nucleotide metabolism in rats.
• Nucleotide ratio changes appear to be an early event that may contribute to the development of orotic acid-induced fatty liver.
• Hepatomegaly is not always concurrent with hepatic steatosis and may be a subsequent development.